SS

Sunandarani Samantaray

Active Director Managing Director DIN 11761281
DIN 11761281 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunandarani Samantaray

Data last updated:

Sunandarani Samantaray is a Managing Director at Viiznox Pharmaceuticals Private Limited (since 2026).

DIN 11761281
Primary Designation Managing Director
First Appointment 09 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director09 Jun 20262026Active

Board colleagues of Sunandarani Samantaray

NameDINCompanyDesignation
Sumitra Lenka11761280Viiznox Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Viiznox Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sunandarani Samantaray

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunandarani Samantaray

Sunandarani Samantaray currently holds 1 directorship: Viiznox Pharmaceuticals Private Limited (Managing Director, since 09 Jun 2026).

Sunandarani Samantaray was first appointed on 09 Jun 2026 as Managing Director at Viiznox Pharmaceuticals Private Limited.

The current boards of Sunandarani Samantaray's companies include Sumitra Lenka (Viiznox Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available